We further examined PTX3 expression in breast cancer tissues of patients: patient one (first-grade tumor, molecular subtype HER2); patient two (second-grade tumor, molecular subtype BLBC); and patient three (third-grade tumor, molecular subtype BLBC). Here, PTX3 is linked to breast carcinoma.